{"id":18013,"date":"2026-04-16T15:06:17","date_gmt":"2026-04-16T13:06:17","guid":{"rendered":"https:\/\/www.bm-t.de\/?p=18013"},"modified":"2026-04-16T15:30:24","modified_gmt":"2026-04-16T13:30:24","slug":"smartdyelivery-secures-million-euro-investment-for-further-growth","status":"publish","type":"post","link":"https:\/\/www.bm-t.de\/en\/2026\/smartdyelivery-secures-million-euro-investment-for-further-growth\/","title":{"rendered":"SmartDyeLivery secures million-Euro investment for further growth"},"content":{"rendered":"

Jena-based Smart\u00adDye\u00adLiv\u00adery GmbH attracts new pri\u00advate investor and suc\u00adcess\u00adfully closes a financ\u00ading round in the mid-dou\u00adble-digit mil\u00adlion range<\/strong><\/p>\n

Jena\/Erfurt\/Austria. Smart\u00adDye\u00adLiv\u00adery GmbH has con\u00advinced an Aus\u00adtrian fam\u00adily office of the poten\u00adtial of its devel\u00adop\u00adments, thereby gain\u00ading a strong new part\u00adner, and suc\u00adcess\u00adfully closed a financ\u00ading round worth millions.<\/p>\n

Smart\u00adDye\u00adLiv\u00adery is devel\u00adop\u00ading a broadly applic\u00ada\u00adble plat\u00adform tech\u00adnol\u00adogy based on poly\u00admeric nanocar\u00adri\u00aders that can be equipped with a nav\u00adi\u00adga\u00adtion sys\u00adtem, thereby enabling the tar\u00adgeted trans\u00adport of active ingre\u00addi\u00adents into tar\u00adget cells. Smart\u00adDye\u00adLiv\u00adery is cur\u00adrently con\u00adduct\u00ading a Phase I clin\u00adi\u00adcal trial in healthy vol\u00adun\u00adteers with its first prod\u00aduct SDL-M1.<\/p>\n

With the new cap\u00adi\u00adtal, Smart\u00adDye\u00adLiv\u00adery plans, as a first step, to move to new premises and to expand its state-of-the-art devel\u00adop\u00adment capa\u00adbil\u00adi\u00adties for prod\u00aducts in its pipeline, as well as to increase the nec\u00ades\u00adsary per\u00adson\u00adnel resources. This is intended to strengthen the company\u2019s posi\u00adtion as a provider of inno\u00adv\u00ada\u00adtive drug deliv\u00adery sys\u00adtems and estab\u00adlish the basis for sus\u00adtain\u00adable growth.<\/p>\n

\u201cThis financ\u00ading round marks a key mile\u00adstone on our growth path,\u201d explains Man\u00adag\u00ading Direc\u00adtor Dr. Marc Lehmann. \u201cWe greatly appre\u00adci\u00adate the new investor\u2019s trust and sup\u00adport. In these chal\u00adleng\u00ading times, we are gain\u00ading a part\u00adner who shares our vision and encour\u00adages us to achieve our ambi\u00adtious goals,\u201d he says, look\u00ading pos\u00adi\u00adtively to the tasks ahead.<\/p>\n

The Smart\u00adDye\u00adLiv\u00adery found\u00ading team, with Pro\u00adfes\u00adsors Ulrich S. Schu\u00adbert, Anja Tr\u00e4ger, and Michael Bauer from Friedrich Schiller Uni\u00adver\u00adsity Jena and Jena Uni\u00adver\u00adsity Hos\u00adpi\u00adtal, adds: \u201cSuch a suc\u00adcess\u00adful trans\u00adla\u00adtion of excel\u00adlent aca\u00add\u00ade\u00admic research into clin\u00adi\u00adcal tri\u00adals demon\u00adstrates the poten\u00adtial inher\u00adent in trans\u00adform\u00ading early research find\u00adings into inde\u00adpen\u00addent spin-offs.\u201d<\/p>\n

\u201cAn invest\u00adment of this mag\u00adni\u00adtude enables Smart\u00adDye\u00adLiv\u00adery to suc\u00adcess\u00adfully tackle the upcom\u00ading chal\u00adlenges and growth phases. How\u00adever, it is not only an impor\u00adtant mile\u00adstone for the com\u00adpany but also a strong sig\u00adnal for the entire inno\u00adva\u00adtion ecosys\u00adtem in Thuringia,\u201d empha\u00adsizes Ste\u00adfan Jahn, Senior Invest\u00adment Man\u00adager at lead investor bm|t, who has been accom\u00adpa\u00adny\u00ading Smart\u00adDye\u00adLiv\u00adery since the very beginning.<\/p>\n

The new investor expressed con\u00adfi\u00addence in the level of devel\u00adop\u00adment achieved to date and in the plat\u00adform technology\u2019s great poten\u00adtial. \u201cWith our invest\u00adment, we aim to actively sup\u00adport SmartDyeLivery\u2019s con\u00adtin\u00adued growth and its planned expan\u00adsion. Both the tech\u00adno\u00adlog\u00adi\u00adcal approach and the goal of help\u00ading patients for whom no or only insuf\u00adfi\u00adcient treat\u00adment options cur\u00adrently exist align with our phi\u00adlos\u00ado\u00adphy,\u201d said the owner of the fam\u00adily office.<\/p>\n

 <\/p>\n

About SmartDyeLivery:<\/strong><\/h4>\n

Smart\u00adDye\u00adLiv\u00adery GmbH, based in Jena, is devel\u00adop\u00ading a uni\u00adver\u00adsal plat\u00adform tech\u00adnol\u00adogy based on func\u00adtion\u00adal\u00adized nanopar\u00adti\u00adcles that can be used to deliver active ingre\u00addi\u00adents or other pay\u00adloads specif\u00adi\u00adcally to the desired site of action. The goal is to pro\u00advide new treat\u00adment options for dis\u00adeases that are cur\u00adrently untreat\u00adable or dif\u00adfi\u00adcult to treat. The inno\u00adv\u00ada\u00adtive, patent-pro\u00adtected tech\u00adnol\u00adogy can also be used for diag\u00adnos\u00adtic or ther\u00ada\u00adnos\u00adtic applications.<\/p>\n

Fur\u00adther infor\u00adma\u00adtion: www.smartdyelivery.com<\/a><\/p>\n

About bm|t<\/strong>:<\/h4>\n

bm|t beteili\u00adgungs\u00adman\u00adage\u00adment th\u00fcrin\u00adgen, based in Erfurt, is the lead\u00ading address for ven\u00adture cap\u00adi\u00adtal invest\u00adments in Thuringia. bm|t cur\u00adrently man\u00adages 12 funds with a total vol\u00adume of around EUR 445 mil\u00adlion, which invest in inno\u00adv\u00ada\u00adtive com\u00adpa\u00adnies in almost all sec\u00adtors and in all phases of com\u00adpany devel\u00adop\u00adment \u2014 both in the start-up and growth phases or in com\u00adpany suc\u00adces\u00adsion sit\u00adu\u00ada\u00adtions. Fur\u00adther infor\u00adma\u00adtion: https:\/\/www.bm\u2011t.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Jena-based Smart\u00adDye\u00adLiv\u00adery GmbH attracts new pri\u00advate investor and suc\u00adcess\u00adfully closes a financ\u00ading round in the mid-dou\u00adble-digit mil\u00adlion range<\/p>\n","protected":false},"author":2,"featured_media":13094,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[288],"tags":[289,159,171,176,177],"class_list":["post-18013","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-288","tag-financing-round","tag-investment-en","tag-thuringia","tag-bm-t-en","tag-bmt-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/posts\/18013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/comments?post=18013"}],"version-history":[{"count":1,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/posts\/18013\/revisions"}],"predecessor-version":[{"id":18014,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/posts\/18013\/revisions\/18014"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/media\/13094"}],"wp:attachment":[{"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/media?parent=18013"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/categories?post=18013"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/tags?post=18013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}